The effect of smartphone-based monitoring on illness activity in bipolar disorder: the MONARCA II randomized controlled single-blinded trial
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
The effect of smartphone-based monitoring on illness activity in bipolar disorder : the MONARCA II randomized controlled single-blinded trial. / Faurholt-Jepsen, Maria; Frost, Mads; Christensen, Ellen Margrethe; Bardram, Jakob E.; Vinberg, Maj; Kessing, Lars Vedel.
In: Psychological Medicine, Vol. 50, No. 5, 2020, p. 838-848.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The effect of smartphone-based monitoring on illness activity in bipolar disorder
T2 - the MONARCA II randomized controlled single-blinded trial
AU - Faurholt-Jepsen, Maria
AU - Frost, Mads
AU - Christensen, Ellen Margrethe
AU - Bardram, Jakob E.
AU - Vinberg, Maj
AU - Kessing, Lars Vedel
PY - 2020
Y1 - 2020
N2 - BackgroundRecently, the MONARCA I randomized controlled trial (RCT) was the first to investigate the effect of smartphone-based monitoring in bipolar disorder (BD). Findings suggested that smartphone-based monitoring sustained depressive but reduced manic symptoms. The present RCT investigated the effect of a new smartphone-based system on the severity of depressive and manic symptoms in BD.MethodsRandomized controlled single-blind parallel-group trial. Patients with BD, previously treated at The Copenhagen Clinic for Affective Disorder, Denmark and currently treated at community psychiatric centres, private psychiatrists or GPs were randomized to the use of a smartphone-based system or to standard treatment for 9 months. Primary outcomes: Differences in depressive and manic symptoms between the groups.ResultsA total of 129 patients with BD (ICD-10) were included. Intention-to-treat analyses showed no statistically significant effect of smartphone-based monitoring on depressive (B = 0.61, 95% CI â'0.77 to 2.00, p = 0.38) and manic (B = â'0.25, 95% CI â'1.1 to 0.59, p = 0.56) symptoms. The intervention group reported higher quality of life and lower perceived stress compared with the control group. In sub-analyses, the intervention group had higher risk of depressive episodes, but lower risk of manic episodes compared with the control group.ConclusionsThere was no effect of smartphone-based monitoring. In patient-reported outcomes, patients in the intervention group reported improved quality of life and reduced perceived stress. Patients in the intervention group had higher risk of depressive episodes and reduced risk of manic episodes. Despite the widespread use and excitement of electronic monitoring, few studies have investigated possible effects. Further studies are needed.
AB - BackgroundRecently, the MONARCA I randomized controlled trial (RCT) was the first to investigate the effect of smartphone-based monitoring in bipolar disorder (BD). Findings suggested that smartphone-based monitoring sustained depressive but reduced manic symptoms. The present RCT investigated the effect of a new smartphone-based system on the severity of depressive and manic symptoms in BD.MethodsRandomized controlled single-blind parallel-group trial. Patients with BD, previously treated at The Copenhagen Clinic for Affective Disorder, Denmark and currently treated at community psychiatric centres, private psychiatrists or GPs were randomized to the use of a smartphone-based system or to standard treatment for 9 months. Primary outcomes: Differences in depressive and manic symptoms between the groups.ResultsA total of 129 patients with BD (ICD-10) were included. Intention-to-treat analyses showed no statistically significant effect of smartphone-based monitoring on depressive (B = 0.61, 95% CI â'0.77 to 2.00, p = 0.38) and manic (B = â'0.25, 95% CI â'1.1 to 0.59, p = 0.56) symptoms. The intervention group reported higher quality of life and lower perceived stress compared with the control group. In sub-analyses, the intervention group had higher risk of depressive episodes, but lower risk of manic episodes compared with the control group.ConclusionsThere was no effect of smartphone-based monitoring. In patient-reported outcomes, patients in the intervention group reported improved quality of life and reduced perceived stress. Patients in the intervention group had higher risk of depressive episodes and reduced risk of manic episodes. Despite the widespread use and excitement of electronic monitoring, few studies have investigated possible effects. Further studies are needed.
KW - Bipolar disorder
KW - depressive and manic symptoms
KW - illness activity
KW - MONARCA II
KW - randomized controlled trial
KW - smartphone
KW - The Monsenso system
U2 - 10.1017/S0033291719000710
DO - 10.1017/S0033291719000710
M3 - Journal article
C2 - 30944054
AN - SCOPUS:85063890728
VL - 50
SP - 838
EP - 848
JO - Psychological Medicine
JF - Psychological Medicine
SN - 0033-2917
IS - 5
ER -
ID: 240315054